Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
← Scanner

AAgilent Technologies, Inc.

Healthcare·Diagnostics & Research·NYSE·Mkt cap $38.00B
$134.29
$0.70 (+0.52%) today
61/100 Opportunity
35Risk
56Momentum
80Pullback
65Quality
68Valuation
65Trend
Price & History (up to 5 years)
2025-07-112026-07-13
Low 109.91— support · — resistanceHigh 156.32
Technical Indicators
RSI (14)58.7
MACD hist-0.23
ATR (14)4.08
SMA 20130.57
SMA 50124.79
SMA 200130.28
Rel volume1.1x
Boll upper136.78
Boll lower124.37
52w high159.33
52w low108.14
5y high173.34
5y low94.82
Hist. vol33%
Max drawdown-30%
Sideways RangeNeutral MomentumPossible Dip BuyEntry: Pullback Watch
Company QualityStable
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Agilent Technologies, Inc. — Diagnostics & Research company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
61/100
Risk Level
Low-Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: A is trading near recent levels (+0.5% today). Overall, the company is reasonably solid. It is in a longer-term sideways range. Short-term momentum is still weak, so confirmation is needed before acting. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality65
Historical Context50
Valuation68
Trend65
Momentum56
Pullback80
News Sentiment50
Business Move50
Sector Strength60
Risk/Reward40
Entry Timing55
Sell Risk30
Risk35

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.